Frontiers in Immunology | Vaccines and Molecular Therapeutics

Original Research

Published on 26 Feb 2025

Development of a multi-epitope vaccine candidate to combat SARS-CoV-2 and dengue virus co-infection through an immunoinformatic approach

in Vaccines and Molecular Therapeutics

Saurav Mandal
Waribam Pratibha Chanu
Kalimuthusamy Natarajaseenivasan

Frontiers in Immunology

doi 10.3389/fimmu.2025.1442101

1,997 views

Original Research

Published on 19 Feb 2025

The protective role of vitamin D in BNT162b2 vaccine-related acute myocarditis

in Vaccines and Molecular Therapeutics

Hing Wai Tsang
Gilbert T. Chua
Keith Tsz Suen Tung
Rosa Sze Man Wong
Sabrina Siu Ling Tsao
Joshua Sung Chih Wong
Joanna Yuet Ling Tung
Janette Siu Yin Kwok
Jason Cheuk Sing Yam
Godfrey Chi Fung Chan

Frontiers in Immunology

doi 10.3389/fimmu.2025.1501609

8,342 views

Mini Review

Published on 18 Feb 2025

Harnessing adjuvant-induced epigenetic modulation for enhanced immunity in vaccines and cancer therapy

in Vaccines and Molecular Therapeutics

Yasmine Megdiche
Rosângela Salerno-Gonçalves

Frontiers in Immunology

doi 10.3389/fimmu.2025.1547213

1,624 views

Original Research

Published on 18 Feb 2025

Dynamics of spike-specific neutralizing antibodies across five-year emerging SARS-CoV-2 variants of concern reveal conserved epitopes that protect against severe COVID-19

in Vaccines and Molecular Therapeutics

Latifa Zayou
Swayam Prakash
Hawa Vahed
Nisha Rajeswari Dhanushkodi
Afshana Quadiri
Ahmed Belmouden
Zohra Lemkhente
Aziz Chentoufi
Daniel Gil
Jeffrey B. Ulmer

Frontiers in Immunology

doi 10.3389/fimmu.2025.1503954

3,570 views
1 citation

Brief Research Report

Published on 17 Feb 2025

XBB.1.5 mRNA COVID-19 vaccine protection against inpatient or emergency department visits among adults infected with SARS-CoV-2 JN.1 and XBB-lineage variants

in Vaccines and Molecular Therapeutics

Matthew E. Levy
Vanessa Chilunda
Phillip R. Heaton
Deran McKeen
Jason D. Goldman
Richard E. Davis
Cynthia A. Schandl
William B. Glen
Lisa M. McEwen
Elizabeth T. Cirulli

Frontiers in Immunology

doi 10.3389/fimmu.2025.1470609

1,763 views
1 citation

Original Research

Published on 17 Feb 2025

Intradermal delivery of SARS-CoV-2 RBD3-Fc mRNA vaccines via a needle-free injection system induces robust immune responses in rats

in Vaccines and Molecular Therapeutics

Cenrong Wang
Xin Tang
Chenghan Jiang
Yu Zhang
Bo Han
Yi Sun
Jianfeng Guo
Hanyu Peng
Zihan Wang
Yipeng Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1530736

1,705 views

Original Research

Published on 14 Feb 2025

Report on adverse events of COVID-19 vaccines in Iran: a comprehensive national prospective longitudinal analysis

in Vaccines and Molecular Therapeutics

Hamidreza Jamaati
Saeed Karimi
Shahnam Arshi
Seyed Mohsen Zahraei
Yunes Panahi
Fatemeh Nouri
Maryam Hajimoradi
Arman Hasanzade
Majid Mokhtari
Katayoun Tayeri

Frontiers in Immunology

doi 10.3389/fimmu.2025.1504973

2,041 views

Original Research

Published on 13 Feb 2025

Designing a potent multivalent epitope vaccine candidate against Orientia tsutsugamushi via reverse vaccinology technique - bioinformatics and immunoinformatic approach

in Vaccines and Molecular Therapeutics

Subhasmita Panda
Subrat Kumar Swain
Basanta Pravas Sahu
Soumya Ranjan Mahapatra
Jyotirmayee Dey
Rachita Sarangi
Anu Vinod Ranade
Namrata Mishra

Frontiers in Immunology

doi 10.3389/fimmu.2025.1513245

1,547 views

Original Research

Published on 13 Feb 2025

Novel mRNA vaccines induce potent immunogenicity and afford protection against tuberculosis

in Vaccines and Molecular Therapeutics

Christopher J. De Voss
Marcellus Korompis
Shuailin Li
Alberta Ateere
Helen McShane
Elena Stylianou

Frontiers in Immunology

doi 10.3389/fimmu.2025.1540359

4,242 views
2 citations

Original Research

Published on 13 Feb 2025

A single point mutation on FLT3L-Fc protein increases the risk of immunogenicity

in Vaccines and Molecular Therapeutics

Dan Qin
Qui Phung
Patrick Wu
Zhaojun Yin
Sien Tam
Peter Tran
Adel M. ElSohly
Joshua Gober
Zicheng Hu
Zhenru Zhou

Frontiers in Immunology

doi 10.3389/fimmu.2025.1519452

1,987 views

Original Research

Published on 12 Feb 2025

A nucleoside-modified mRNA vaccine prevents enterovirus A71 infection in mouse model

in Vaccines and Molecular Therapeutics

Fengyu Chi
Xu Zhang
Dong Zhang
Airu Zhu
Zhen Zhuang
Zhaoyong Zhang
Zhenjie Zhang
Chuansong Quan
Kaixiao Nie
Juan Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1535758

2,301 views
1 citation

Original Research

Published on 07 Feb 2025

Adjuvanted subunit intranasal vaccine reduces SARS-CoV-2 onward transmission in hamsters

in Vaccines and Molecular Therapeutics

Yongjun Sui
Swagata Kar
Bhavna Chawla
Tanya Hoang
YuanKai Yu
Shannon M. Wallace
Hanne Andersen
Jay A. Berzofsky

Frontiers in Immunology

doi 10.3389/fimmu.2025.1514845

1,939 views
1 citation

Original Research

Published on 06 Feb 2025

BAFF and APRIL immunotherapy following Bacille Calmette-Guérin vaccination enhances protection against pulmonary tuberculosis in mice

in Vaccines and Molecular Therapeutics

Min Xie
Chen-Yu Tsai
Joshua Woo
Frank Nuritdinov
Melissa Cristaldo
Narineh M. Odjourian
Rosleine Antilus-Sainte
Maureen Dougher
Martin Gengenbacher

Frontiers in Immunology

doi 10.3389/fimmu.2025.1551183

1,839 views

Original Research

Published on 06 Feb 2025

Comparison of air-liquid interface transwell and airway organoid models for human respiratory virus infection studies

in Vaccines and Molecular Therapeutics

Camilla T. Ekanger
Nilima Dinesh Kumar
Rosanne W. Koutstaal
Fan Zhou
Martin Beukema
Joanna Waldock
Simon P. Jochems
Noa Mulder
Cécile A. C. M. van Els
Othmar G. Engelhardt

Frontiers in Immunology

doi 10.3389/fimmu.2025.1532144

4,661 views
3 citations

Correction

Published on 05 Feb 2025

Corrigendum: Brucella suis ΔmapB outer membrane vesicles as an acellular vaccine against systemic and mucosal B. suis infection

in Vaccines and Molecular Therapeutics

Florencia Muñoz González
Magali G. Bialer
Maria L. Cerutti
Silvia M. Estein
Lila Y. Ramis
Pablo C. Baldi
Ángeles Zorreguieta
Mariana C. Ferrero

Frontiers in Immunology

doi 10.3389/fimmu.2025.1565688

757 views

Original Research

Published on 04 Feb 2025

Discovery and in vitro characterization of a human anti-CD36 scFv

in Vaccines and Molecular Therapeutics

Cecilia Mata-Cruz
Sandra L. Guerrero-Rodríguez
Keyla Gómez-Castellano
Gregorio Carballo-Uicab
Juan Carlos Almagro
S. Mayra Pérez-Tapia
Marco A. Velasco-Velázquez

Frontiers in Immunology

doi 10.3389/fimmu.2025.1531171

2,537 views